Literature DB >> 8906852

Defective Fc gamma RII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum.

J J Luan1, R C Monteiro, C Sautès, G Fluteau, L Eloy, W H Fridman, J F Bach, H J Garchon.   

Abstract

A quantitative trait locus for increased IgG serum levels in the NOD mouse strain was mapped to distal chromosome 1, close to the fcgr2 locus encoding the low-affinity type II receptor for the Fc portion of IgG (Fc gamma RII). Expression of membrane-inserted (b2) and soluble (b3) isoforms of Fc gamma RII was strongly decreased in macrophages of NOD compared with C57BL/6 (B6) mice. In contrast, B cell-specific (Fc gamma RIIb1) isoform was only slightly decreased and Fc gamma RIII was not altered. This Fc gamma RII regulatory defect was cis-encoded by fcgr2 or by a closely linked locus, occurred at the mRNA level, and was associated with multiple mutations in the fcgr2 gene promoter. In relation with this defect, binding of IgG1- and IgG2b- but not IgG2a-opsonized RBC by macrophages of NOD and congenic B6.NOD-fcgr2 mice was severely impaired, but was normal in macrophages of NOD.B6-fcgr2 congenic mice, indicating that Fc gamma RII plays a nondispensable role in binding of IgG1 and IgG2b isotypes. Likewise, serum levels of IgG1 and IgG2b but not IgG2a were up-regulated in NOD compared with NOD.B6-fcgr2 congenic mice. These findings indicate that macrophage Fc gamma RII may regulate serum IgG1 and IgG2b through their catabolism, and validate the NOD strain as a model to investigate the functions of Fc gamma RII isoforms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906852

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  B cell inhibitory receptors and autoimmunity.

Authors:  Nicholas R Pritchard; Kenneth G C Smith
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus.

Authors:  Marissa C Blank; Radu N Stefanescu; Emi Masuda; Francesc Marti; Philip D King; Patricia B Redecha; Robert J Wurzburger; Margaret G E Peterson; Shizuko Tanaka; Luminita Pricop
Journal:  Hum Genet       Date:  2005-05-14       Impact factor: 4.132

Review 4.  FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

Authors:  Kenneth G C Smith; Menna R Clatworthy
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

5.  Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.

Authors:  Viqar S Banday; Radha Thyagarajan; Mia Sundström; Kristina Lejon
Journal:  Immunology       Date:  2016-08-23       Impact factor: 7.397

6.  B cell depletion: a novel therapy for autoimmune diabetes?

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Gain-of-function mutations in FcgammaRI of NOD mice: implications for the evolution of the Ig superfamily.

Authors:  A L Gavin; P S Tan; P M Hogarth
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

Review 8.  Inhibitory Fc gamma receptors: from gene to disease.

Authors:  Radu N Stefanescu; Mikhail Olferiev; Yi Liu; Luminita Pricop
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

9.  Genetic influences on the end-stage effector phase of arthritis.

Authors:  H Ji; D Gauguier; K Ohmura; A Gonzalez; V Duchatelle; P Danoy; H J Garchon; C Degott; M Lathrop; C Benoist; D Mathis
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

10.  Analysis of a wild mouse promoter variant reveals a novel role for FcγRIIb in the control of the germinal center and autoimmunity.

Authors:  Marion Espéli; Menna R Clatworthy; Susanne Bökers; Kate E Lawlor; Antony J Cutler; Frank Köntgen; Paul A Lyons; Kenneth G C Smith
Journal:  J Exp Med       Date:  2012-10-29       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.